Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
ADAM17 and its inhibitor TIMP3 are involved in nephropathy, but their role in diabetic kidney disease (DKD) is unclear. Diabetic Timp3 −/− mice showed increased albuminuria, increased membrane thickness and mesangial expansion. Microarray profiling uncovered a significant reduction of Foxo1 expression in diabetic Timp3 −/− mice compared to WT, along with FoxO1 target genes involved in autophagy, while STAT1, a repressor of FoxO1 transcription, was increased. Re‐expression of Timp3 in Timp3 −/− mesangial cells rescued the expression of Foxo1 and its targets, and decreased STAT1 expression to control levels; abolishing STAT1 expression led to a rescue of FoxO1, evoking a role of STAT1 in linking Timp3 deficiency to FoxO1. Studies on kidney biopsies from patients with diabetic nephropathy confirmed a significant reduction in TIMP3, FoxO1 and FoxO1 target genes involved in autophagy compared to controls, while STAT1 expression was strongly increased. Our study suggests that loss of TIMP3 is a hallmark of DKD in human and mouse models and designates TIMP3 as a new possible therapeutic target for diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“restoration of TIMP3 expression in GMCs from Timp3−/− mice by transfection with a Timp3 adenovirus reversed the impairment in autophagy.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cultured GMCs exposed to high-glucose, Timp3 deletion suppressed autophagy by reducing the expression of FOXO1a and its target ATG genes”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
The cited source says what the claim attributes to it.
In the citing paper
“Timp3 deletion exacerbated diabetic kidney injury in mice160.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
In the citing paper
“The metalloproteinase inhibitor 3 gene (Timp3) was downregulated in the kidney of STZ-induced diabetic mice and in patients with diabetes, as well as in GMCs treated with high glucose”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [160]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“…be induced by intracellular stresses that are involved in the pathogenesis of diabetic nephropathy including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et…”
[9] TM4 Microarray Software Suite
Saeed, A. I., Bhagabati, N. K., Braisted, J. C., Liang, W., Sharov, V., Howe, E. A., Li, J., Thiagarajan, M., White, J. A., & Quackenbush, J. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)11009-5 · Cited by 1,983 · cited 1×
“Heatmaps and hierarchical clusters were created using MeV 4.4 (MultiExperiment Viewer, TM4 suite; Saeed et al, 2006).”
InfluentialZhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
Autophagy is required to maintain muscle mass.
Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M., Metzger, D., Reggiani, C., Schiaffino, S., & Sandri, M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.008 · Cited by 1,282 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090 · cited 1×
“ADAM17, also known as TNF-a converting enzyme (TACE), mediates the shedding of TNF-a and its receptors (TNFRI and II), adhesion molecules ( L -selectin, VCAM), and several EGFR ligands, such as amphiregulin, TGF-a and heparin-binding EGF-Research like growth factor (HB-EGF; Blobel, 2000, 2005).”
The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy
Mogensen, C. E., Christensen, C. K., & Vittinghus, E. (1983) · Diabetes · doi:10.2337/diab.32.2.s64 · Cited by 967 · cited 1×
“Poor glycaemic control and elevated systolic blood pressure exacerbate proteinuria and renal injury that may culminate in end-stage renal disease (Lane et al, 1990; Mogensen et al, 1983).”
Redox Regulation of Forkhead Proteins Through a p66shc -Dependent Signaling Pathway
Nemoto, S., & Finkel, T. (2002) · Science · doi:10.1126/science.1069004 · Cited by 818 · cited 2×
“…2D FoxO1 regulation in diabetic Timp3 (cid:1) / (cid:1) kidneys Giving the importance of FoxO1 in regulating cell survival and oxidative stress (Nemoto & Finkel, 2002), and renal neoplastic cell proliferation (Gan et al, 2010), we next focused on FoxO1 regulation in STZ-Timp3 (cid:1) / (cid:1)…”
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721 · cited 1×
“…including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et al, 2011; Hartleben et al, 2010; He et al, 2010; Inoki et al, 2011; Kume et al, 2010; Nath, 2010).”
Hariharan, N., Maejima, Y., Nakae, J., Paik, J., DePinho, R. A., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.110.227371 · Cited by 692 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658 · cited 2×
“Through gene expression profiling of Timp3 (cid:1) / (cid:1) diabetic kidneys, our study confirms that many critical mediators of inflammation and proliferation are found up-regulated, although we did not observe a perturbation of the VEGFR pathway that has been reported to bind TIMP3 (Qi et al, 2003).”
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642 · cited 1×
“…of human DKD biopsies, TIMP3 was significantly down-regulated in glomeruli but not in tubuli of diabetic kidneys compared to their healthy controls (Woroniecka et al, 2011), and it is therefore possible that TIMP3 may have different roles in these distinct compartments, and/or may be…”
Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S.-I., Sugimoto, T., Haneda, M., Kashiwagi, A., & Koya, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41376 · Cited by 640 · cited 2×
“…including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et al, 2011; Hartleben et al, 2010; He et al, 2010; Inoki et al, 2011; Kume et al, 2010; Nath, 2010).”
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638 · cited 1×
“Diabetic kidney disease (DKD) is one of the most severe complications associated with both type 1 and type 2 diabetes, developing in about one-third of diabetic patients (Groop et al, 2009).”
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity
Zhao, Y., Yang, J., Liao, W., Liu, X., Zhang, H., Wang, S., Wang, D., Feng, J., Yu, L., & Zhu, W.-G. (2010) · Nature Cell Biology · doi:10.1038/ncb2069 · Cited by 606 · cited 1×
“However, Zhao and colleagues recently described a different mechanism in which the cytoplasmic pool of acetylated FoxO1 molecules appeared to be essential for induction of autophagy (Zhao et al, 2010), and FoxO1-mediated induction of autophagy was independent of FoxO1 transcriptional activity.”
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547 · cited 2×
“…of diabetic nephropathy through intracellular stress induced-autophagy (such as AMPK and mTOR activity, hypoxia and ER stress; Fogo, 2011; Godel et al, 2011; He et al, 2010; Inoki et al, 2011; Kume et al, 2010, 2012; Nath, 2010) were not affected in our models (Supporting Information Fig…”
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538 · cited 2×
“…including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et al, 2011; Hartleben et al, 2010; He et al, 2010; Inoki et al, 2011; Kume et al, 2010; Nath, 2010).”
Frescas, D., Valenti, L., & Accili, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412357200 · Cited by 533 · cited 1×
“…and similarly to STZ-Timp3 (cid:1) / (cid:1) kidney, higher inflammatory response (up-regulation of ccl2 and down-regulation of IkBalpha exclusion (Frescas et al, 2005) along with a decline of its transcriptional activity; recent studies have demonstrated that FoxO1 acetylation results in its…”
Self-citationCirculating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Niewczas, M. A., Gohda, T., Skupien, J., Smiles, A. M., Walker, W. H., Rosetti, F., Cullere, X., Eckfeldt, J. H., Doria, A., Mayadas, T. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060627 · Cited by 485 · cited 1×
“Recently, it has been shown that elevated serum concentrations of soluble TNFRI and II are strong predictor of early renal function loss either in type 1 and type 2 diabetes (Gohda et al, 2012; Niewczas et al, 2012).”
FoxO Transcription Factors Promote Autophagy in Cardiomyocytes
Sengupta, A., Molkentin, J. D., & Yutzey, K. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024406 · Cited by 428 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
The Notch pathway in podocytes plays a role in the development of glomerular disease
Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., & Susztak, K. (2008) · Nature Medicine · doi:10.1038/nm1731 · Cited by 427 · cited 15×
“To test the role of TIMP3 and ADAM17 in DKD we treated C57Bl6 WT mice with streptozocin (STZ) to induce hypergly-caemia.”
InfluentialFederici, M., Menghini, R., Mauriello, A., Hribal, M. L., Ferrelli, F., Lauro, D., Sbraccia, P., Spagnoli, L. G., Sesti, G., & Lauro, R. (2002) · Circulation · doi:10.1161/01.cir.0000023043.02648.51 · Cited by 373 · cited 1×
“This unexplored effect of TIMP3 on FoxO1 function in the kidney is dependent on a hyperglycaemic environment which contributes to reduce TIMP3 expression possibly through epigenetic regulation of its promoter (Cardellini et al, 2009; Federici et al, 2002).”
Self-citationRole of matrix metalloproteinases in renal pathophysiologies
Catania, J. M., Chen, G., & Parrish, A. R. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00421.2006 · Cited by 372 · cited 2×
“Recent data suggest a role for MMPs in a number of acute and chronic renal disorders (Catania et al, 2007).”
Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356 · cited 1×
“Recently, it has been shown that elevated serum concentrations of soluble TNFRI and II are strong predictor of early renal function loss either in type 1 and type 2 diabetes (Gohda et al, 2012; Niewczas et al, 2012).”
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
Lautrette, A., Li, S., Alili, R., Sunnarborg, S. W., Burtin, M., Lee, D. C., Friedlander, G., & Terzi, F. (2005) · Nature Medicine · doi:10.1038/nm1275 · Cited by 343 · cited 2×
“ATII also causes redistribution of the metalloprotease ADAM17 to the apical membrane of renal tubules (Lautrette et al, 2005).”
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Ruggenenti, P., Cravedi, P., & Remuzzi, G. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.58 · Cited by 319 · cited 1×
“Current therapies for DKD, such as blood glucose control, angiotensin II (ATII) receptors blockers and ACE inhibitors, slow down, but do not halt, the progression of this pathology (Ruggenenti et al, 2010).”
Sirt1 activation protects the mouse renal medulla from oxidative injury
He, W., Wang, Y., Zhang, M.-Z., You, L., Davis, L. S., Fan, H., Yang, H.-C., Fogo, A. B., Zent, R., Harris, R. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41563 · Cited by 317 · cited 2×
“…including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et al, 2011; Hartleben et al, 2010; He et al, 2010; Inoki et al, 2011; Kume et al, 2010; Nath, 2010).”
The Extending Network of FOXO Transcriptional Target Genes
van der Vos, K. E., & Coffer, P. J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3419 · Cited by 243 · cited 1×
“FoxO transcription factors are implicated in regulating diverse cellular functions, including differentiation, proliferation, metabolism and survival (Hedrick, 2009; van der Vos & Coffer, 2011).”
Bollée, G., Flamant, M., Schordan, S., Fligny, C., Rumpel, E., Milon, M., Schordan, E., Sabaa, N., Vandermeersch, S., Galaup, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2491 · Cited by 237 · cited 2×
“This latter class of molecules have been implicated in the development of renal inflammatory and fibrotic lesions in mice (Bollee et al, 2011).”
Remarkable roles of proteolysis on and beyond the cell surface
Blobel, C. P. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00139-3 · Cited by 231 · cited 1×
“ADAM17, also known as TNF-a converting enzyme (TACE), mediates the shedding of TNF-a and its receptors (TNFRI and II), adhesion molecules ( L -selectin, VCAM), and several EGFR ligands, such as amphiregulin, TGF-a and heparin-binding EGF-Research like growth factor (HB-EGF; Blobel, 2000, 2005).”
JNK regulates FoxO-dependent autophagy in neurons
Xu, P., Das, M., Reilly, J., & Davis, R. J. (2011) · Genes & Development · doi:10.1101/gad.1984311 · Cited by 216 · cited 1×
“…and FoxO3A target genes were shown to be involved in autophagic protection of skeletal myocytes, cardiomyocytes and neurons from stress conditions (Hariharan et al, 2010; Masiero et al, 2009; Medema & Jaattela, 2010; Sengupta et al, 2009; van der Vos et al, 2011; Xu et al, 2011; Zhao et al, 2007).”
The role of ADAM-mediated shedding in vascular biology
Dreymueller, D., Pruessmeyer, J., Groth, E., & Ludwig, A. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.09.003 · Cited by 208 · cited 1×
“Theseenzymesbelongtothemetalloproteinase class of enzymes which also comprise matrix metalloproteinases (MMPs) known for the continuous remodelling of the extra-cellular matrix and cleavage of cell surface proteins (Dreymueller et al, 2012).”
Federici, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26052 · Cited by 163 · cited 1×
“Timp3 (cid:1) / (cid:1) mice were previously described (Federici et al, 2005).”
Self-citationThe cunning little vixen: Foxo and the cycle of life and death
Hedrick, S. M. (2009) · Nature Immunology · doi:10.1038/ni.1784 · Cited by 157 · cited 1×
“FoxO transcription factors are implicated in regulating diverse cellular functions, including differentiation, proliferation, metabolism and survival (Hedrick, 2009; van der Vos & Coffer, 2011).”
Nutrient Sensing, Autophagy, and Diabetic Nephropathy
Kume, S., Thomas, M. C., & Koya, D. (2012) · Diabetes · doi:10.2337/db11-0555 · Cited by 157 · cited 3×
“Autophagy can also be induced by intracellular stresses that are involved in the pathogenesis of diabetic nephropathy including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes…”
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
Gan, B., Lim, C., Chu, G., Hua, S., Ding, Z., Collins, M., Hu, J., Jiang, S., Fletcher-Sananikone, E., Zhuang, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.019 · Cited by 144 · cited 1×
“…FoxO1 regulation in diabetic Timp3 (cid:1) / (cid:1) kidneys Giving the importance of FoxO1 in regulating cell survival and oxidative stress (Nemoto & Finkel, 2002), and renal neoplastic cell proliferation (Gan et al, 2010), we next focused on FoxO1 regulation in STZ-Timp3 (cid:1) / (cid:1) kidney.”
Metalloproteinases, inflammation, and rheumatoid arthritis
Mohammed, F. F., Smookler, D. S., & Khokha, R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii43 · Cited by 142 · cited 2×
“ADAMs are transmembrane proteins with shedding activity acting on a variety of substrates localized in the plasma membrane to generate inflammatory, growth, migration and metabolic signals.”
Self-citationLoss of TIMP3 Enhances Interstitial Nephritis and Fibrosis
Kassiri, Z., Oudit, G. Y., Kandalam, V., Awad, A., Wang, X., Ziou, X., Maeda, N., Herzenberg, A. M., & Scholey, J. W. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050492 · Cited by 142 · cited 5×
“TIMP3 is the most highly expressed TIMP in the kidney and has a broad protease inhibition profile; loss of this protein is associated with age-dependent renal fibrosis and tubulointerstitial injury in mice (Kassiri et al, 2009; Kawamoto et al, 2006).”
InfluentialCardellini, M., Menghini, R., Martelli, E., Casagrande, V., Marino, A., Rizza, S., Porzio, O., Mauriello, A., Solini, A., Ippoliti, A., et al. (2009) · Diabetes · doi:10.2337/db09-0280 · Cited by 142 · cited 1×
“This unexplored effect of TIMP3 on FoxO1 function in the kidney is dependent on a hyperglycaemic environment which contributes to reduce TIMP3 expression possibly through epigenetic regulation of its promoter (Cardellini et al, 2009; Federici et al, 2002).”
Self-citationMurthy, A., Shao, Y. W., Narala, S., Molyneux, S. D., Zúñiga‐Pflücker, J. C., & Khokha, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.005 · Cited by 138 · cited 1×
“ADAM17 is also involved in the cleavage of Notch in the plasma membrane to generate the Notch intra-cellular domain (NICD), which then moves to the nucleus to regulate gene expression (Murthy et al, 2012).”
Self-citationLin, C.-L., Wang, F.-S., Hsu, Y.-C., Chen, C.-N., Tseng, M.-J., Saleem, M. A., Chang, P.-J., & Wang, J.-Y. (2010) · Diabetes · doi:10.2337/db09-0663 · Cited by 127 · cited 13×
“To test the role of TIMP3 and ADAM17 in DKD we treated C57Bl6 WT mice with streptozocin (STZ) to induce hypergly-caemia.”
InfluentialBlack, R. A. (2004) · Nature Genetics · doi:10.1038/ng0904-934 · Cited by 103 · cited 1×
“These effects arise due to unrestrained activation of ADAM17 which results in a systemic increase in TNF-a signalling and additionally in EGFR activation (Black, 2004).”
Fogo, A. B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57935 · Cited by 74 · cited 2×
“…in the pathogenesis of diabetic nephropathy through intracellular stress induced-autophagy (such as AMPK and mTOR activity, hypoxia and ER stress; Fogo, 2011; Godel et al, 2011; He et al, 2010; Inoki et al, 2011; Kume et al, 2010, 2012; Nath, 2010) were not affected in our models (Supporting…”
Banks, A. S., Kim-Muller, J. Y., Mastracci, T. L., Kofler, N. M., Qiang, L., Haeusler, R. A., Jurczak, M. J., Laznik, D., Heinrich, G., Samuel, V. T., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.012 · Cited by 67 · cited 2×
“…/ (cid:1) kidney, higher inflammatory response (up-regulation of ccl2 and down-regulation of IkBalpha exclusion (Frescas et al, 2005) along with a decline of its transcriptional activity; recent studies have demonstrated that FoxO1 acetylation results in its loss of function (Banks et al, 2011).”
Self-citationKidney complications: Factors that protect the diabetic vasculature
Rask‐Madsen, C., & King, G. L. (2010) · Nature Medicine · doi:10.1038/nm0110-40 · Cited by 43 · cited 1×
“…and inhibit downstream signalling and angiogenesis (Qi et al, 2003), and evidence is emerging that VEGF plays a crucial role in maintaining renal homeostasis, as altered (increased or decreased) expression of VEGF leads to glomerular dysfunction and proteinuria (Rask-Madsen & King, 2010).”
Cytosolic FoxO1: alive and killing
Medema, R. H., & Jäättelä, M. (2010) · Nature Cell Biology · doi:10.1038/ncb0710-642 · Cited by 37 · cited 1×
“…be induced by intracellular stresses that are involved in the pathogenesis of diabetic nephropathy including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et…”
Ono, M., Chia, D. J., Merino-Martinez, R., Flores-Morales, A., Unterman, T. G., & Rotwein, P. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0543 · Cited by 36 · cited 2×
“As STAT family members have been loosely implicated in the regulation of FoxO1 promoter, and STAT1 in particular has a negative effect on FoxO1 transcription (Luo et al, 2011; Ono et al, 2007), we next analysed STAT1 expression in mice.”
Mäkelä, O. T., Lammi, M. J., Uusitalo‐Järvinen, H., Hyttinen, M. M., Vuorio, E., Helminen, H. J., & Tulamo, R.-M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.1.43 · Cited by 35
Regulation of autophagy by Forkhead box (FOX) O transcription factors
van der Vos, K. E., Gomez‐Puerto, M. C., & Coffer, P. J. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.10.002 · Cited by 30
The role of Sirt1 in renal rejuvenation and resistance to stress
Nath, K. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42184 · Cited by 24 · cited 4×
“Autophagy can also be induced by intracellular stresses that are involved in the pathogenesis of diabetic nephropathy including hypoxia or ER stress (Kume et al, 2012; Mizushima & Komatsu, 2011), and plays an important role as a survival factor especially in post-mitotic cells such as podocytes (Fogo, 2011; Godel et a…”
InfluentialRenal histologic changes in diabetes mellitus.
Lane, P. H., Steffes, M. W., & Mauer, S. M. (1990) · PubMed · Cited by 23
Kawamoto, H., Yasuda, O., Suzuki, T., OZAKI, T., Yotsui, T., Higuchi, M., Rakugi, H., Fukuo, K., Ogihara, T., & Maeda, N. (2006) · Hypertension Research · doi:10.1291/hypres.29.285 · Cited by 22 · cited 3×
“TIMP3 is the most highly expressed TIMP in the kidney and has a broad protease inhibition profile; loss of this protein is associated with age-dependent renal fibrosis and tubulointerstitial injury in mice (Kassiri et al, 2009; Kawamoto et al, 2006).”
Transcription factors regulate Forkhead box O1 gene promoter activity in pancreatic ?-cells
Luo, Y. (2011) · Asian Biomedicine · doi:10.5372/7878 · Cited by 3
Luo, Y., Yan, L., & Han, X. (2011) · Asian Biomedicine · doi:10.5372/1905-7415.0504.057 · Cited by 3 · cited 2×
“As STAT family members have been loosely implicated in the regulation of FoxO1 promoter, and STAT1 in particular has a negative effect on FoxO1 transcription (Luo et al, 2011; Ono et al, 2007), we next analysed STAT1 expression in mice.”
Cited by
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
“MicroRNAs (miRs) play important roles in the initiation and progression of many pathological processes, such as diabetic nephropathy [69] and retinopathy [112].”
BackgroundAutophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
The return of the nucleus: transcriptional and epigenetic control of autophagy
Füllgrabe, J., Klionsky, D. J., & Joseph, B. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3716 · Cited by 466
Autophagy in diabetic nephropathy
Ding, Y., & Choi, M. E. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0437 · Cited by 306
“Furthermore, knockdown of TIMP3 in mesangial cells, either by shRNA or genetic deletion in primary mesangial cells obtained from Timp3-null mice, recapitulated FOXO1 downregulation in vivo and inhibition of autophagy (Fiorentino et al. 2013).”
BackgroundInfluentialRegulation of autophagy by stress-responsive transcription factors
Pietrocola, F., Izzo, V., Niso-Santano, M., Vacchelli, E., Galluzzi, L., Maiuri, M. C., & Kroemer, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.008 · Cited by 268
Metadata
- Authors
- Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, F., Casagrande, V., Menghini, R., Pontrelli, P., Arisi, I., D'Onofrio, M., Lauro, D., Khokha, R., Accili, D., Pugliese, G., Gesualdo, L., Lauro, R., & Federici, M.
- Affiliations
- University of Rome Tor Vergata (IT)
- Sapienza University of Rome (IT)
- University of Bari Aldo Moro (IT)
- European Brain Research Institute (IT)
- University of Toronto (CA)
- Columbia University (US)
- Corresponding author
- Federici, Massimo
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2013-02-12
- Volume
- 5
- Issue
- 3
- Pages
- 441-455
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3598083
- OpenAlex
- W1917997699
- Cited by
- 98
- References
- 53
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 12 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 7 · 2014: 10 · 2013: 9
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK057539)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- TIMP-3, diabetic nephropathy, FOXO1, STAT1, ADAM17, autophagy, albuminuria, mesangial expansion, therapeutic target
- MeSH terms
- Forkhead Box Protein O1, Albuminuria, Animals, Autophagy, Biopsy, Cell Line, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Gene Expression Regulation, Humans, Kidney Glomerulus, Transfection, Signal Transduction, Mice, Knockout, Tissue Inhibitor of Metalloproteinase-3, Gene Expression Profiling, RNA Interference, Mesangial Cells, STAT1 Transcription Factor, Mice, Forkhead Transcription Factors, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.